查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390857

2023-2028 年藥物器材組合產品市場報告（按產品、應用、最終用戶和地區）

Drug Device Combination Products Market Report by Product, Application, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球藥物器材組合產品市場規模達到1,436億美元。展望未來， IMARC Group預計到2028年市場規模將達到2,304億美元，2022-2028年複合年成長率（CAGR）為8.20%。

藥物器械組合產品包括醫療器械和藥物成分，有助於將藥物輸送到患者體內的特定位置。它們包括包裝有輸送裝置的疫苗瓶、帶有手術單和麻醉拭子的手術托盤，以及預裝藥物輸送系統，如注射器、胰島素注射筆和定量吸入器。常見的藥物器械組合產品包括單株抗體與治療藥物的組合、帶有類固醇塗層尖端的起搏導線、帶有抗菌塗層的導管以及含有繃帶和紗布的急救包等。

藥物器材組合產品市場趨勢：

慢性病的日益普及以及對疾病治療新方法的需求不斷增加是推動全球藥物器材組合產品採用的關鍵因素。這些產品可以幫助患有癌症、心臟病、多發性硬化症、腦性麻痺、脊髓損傷、貧血、肝炎、類風濕性關節炎、糖尿病和其他嚴重疾病的患者。此外，這些產品還具有一些優點，例如副作用最小、藥物給藥受控、患者依從性提高以及標靶藥物傳輸。再加上人們對智慧和精準藥物傳輸系統的日益青睞，這些系統可以減少治療效果所需的藥物量，從而促進了市場的成長。除此之外，市場參與者正在將技術融入藥物器材組合產品中，以用於追蹤和監控目的。他們還推出了使用複雜的活性成分、配方、遞送途徑和劑型製成的複雜產品，例如胜肽、脂質體和經皮製劑。此外，他們還專注於開發具有高黏度、配方和新型生物製劑的下一代產品。因此，預計對這些產品的需求將會上升，以便為患者提供更好地堅持治療的治療和解決方案。

本報告回答的關鍵問題：

  • 迄今為止，全球藥物器械組合產品市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球藥物器材組合產品市場有何影響？
  • 主要區域市場有哪些？
  • 基於產品的市場區隔是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球藥物器材組合產品市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球藥物器材組合產品市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 藥物洗脫支架
    • 市場走向
    • 市場預測
  • 經皮貼劑
    • 市場走向
    • 市場預測
  • 點滴幫浦
    • 市場走向
    • 市場預測
  • 藥物洗脫球囊
    • 市場走向
    • 市場預測
  • 吸入器
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按應用分類的市場區隔

  • 心血管
    • 市場走向
    • 市場預測
  • 糖尿病
    • 市場走向
    • 市場預測
  • 癌症治療
    • 市場走向
    • 市場預測
  • 呼吸疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Baxter International Inc.
    • Bayer AG
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Medtronic plc
    • Novartis AG
    • Smith & Nephew plc
    • Stryker Corporation
    • Terumo Corporation
Product Code: SR112023A4751

Abstract

The global drug device combination products market size reached US$ 143.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 230.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.20% during 2022-2028.

Drug device combination products comprise medical devices and pharmaceutical ingredients, which assist in delivering the drug to a specific location in the patient's body. They include vaccine vials packaged with a delivery device, surgical trays with drapes and anesthetic swabs, and prefilled drug delivery systems like syringes, insulin injector pens, and metered dose inhalers. Some of the commonly available drug device combination products are monoclonal antibody combined with a therapeutic drug, pacing lead with steroid-coated tip, and catheter with an antimicrobial coating, and first-aid kits containing bandages and gauze are some.

Drug Device Combination Products Market Trends:

The growing prevalence of chronic diseases and the escalating demand for new approaches in treating diseases are among the key factors driving the adoption of drug device combination products across the globe. These products help patients suffering from cancer, heart disease, multiple sclerosis, cerebral palsy, spinal cord injuries, anemia, hepatitis, rheumatoid arthritis, diabetes, and other serious conditions. Moreover, these products offer advantages, such as minimal side effects, controlled drug administration, improved patient compliance, and targeted drug delivery. This, coupled with increasing preferences for smart and precision drug delivery systems that reduce the amount of drug required for therapeutic efficacy, is contributing to the market growth. Apart from this, market players are incorporating technologies into drug device combination products for tracking and monitoring purposes. They are also introducing sophisticated products made using complex active ingredients, formulations, routes of delivery, and dosage forms, such as peptides, liposomes, and transdermal. Additionally, they are focusing on developing next-generation products with high viscosity, formulations, and new classes of biologics. As a result, the demand for these products is anticipated to rise for providing patients treatments and solutions that can better adhere to their therapy.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug device combination products market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Drug Eluting Stents

Transdermal Patches

Infusion Pumps

Drug Eluting Balloon

Inhalers

Others

Breakup by Application:

Cardiovascular

Diabetes

Cancer Treatment

Respiratory Diseases

Others

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Boston Scientific Corporation, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Novartis AG, Smith & Nephew plc, Stryker Corporation and Terumo Corporation.

Key Questions Answered in This Report:

  • How has the global drug device combination products market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug device combination products market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug device combination products market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Device Combination Products Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Drug Eluting Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transdermal Patches
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Infusion Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Drug Eluting Balloon
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Inhalers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Cardiovascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diabetes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cancer Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Respiratory Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boston Scientific Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GlaxoSmithKline plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novartis AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smith & Nephew plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Device Combination Products Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Device Combination Products Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Drug Device Combination Products Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Drug Device Combination Products Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Drug Device Combination Products Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Drug Device Combination Products Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Drug Device Combination Products Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Drug Device Combination Products (Drug Eluting Stents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Drug Device Combination Products (Drug Eluting Stents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Drug Device Combination Products (Transdermal Patches) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Drug Device Combination Products (Transdermal Patches) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Drug Device Combination Products (Infusion Pumps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Drug Device Combination Products (Infusion Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Drug Device Combination Products (Drug Eluting Balloon) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Drug Device Combination Products (Drug Eluting Balloon) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Drug Device Combination Products (Inhalers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Drug Device Combination Products (Inhalers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Drug Device Combination Products (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Drug Device Combination Products (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Drug Device Combination Products (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Drug Device Combination Products (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Drug Device Combination Products (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Drug Device Combination Products (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Drug Device Combination Products (Cancer Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Drug Device Combination Products (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Drug Device Combination Products (Respiratory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Drug Device Combination Products (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Drug Device Combination Products (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Drug Device Combination Products (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Drug Device Combination Products (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Drug Device Combination Products (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Drug Device Combination Products (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Drug Device Combination Products (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Drug Device Combination Products (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Drug Device Combination Products (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Drug Device Combination Products Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Drug Device Combination Products Industry: SWOT Analysis
  • Figure 86: Global: Drug Device Combination Products Industry: Value Chain Analysis
  • Figure 87: Global: Drug Device Combination Products Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Device Combination Products Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Drug Device Combination Products Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Drug Device Combination Products Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Drug Device Combination Products Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Drug Device Combination Products Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Drug Device Combination Products Market: Competitive Structure
  • Table 7: Global: Drug Device Combination Products Market: Key Players